Vaxart (OTCMKTS:VXRT) used its fourth-quarter business update and year-end 2025 financial results conference call to highlight a new partnership for its oral COVID-19 vaccine candidate, updates on an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results